Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Application of target-specific drug immunoconjugates to experimental bone marrow replacement therapy in mice.

Ding L, Yu LZ, Xie SS, Gong D, Vergidis R, Diener E.

Cancer Res. 1990 Mar 1;50(5):1538-43.

2.

Facilitation of allogeneic bone marrow transplantation by a T cell-specific immunotoxin containing daunomycin.

Xie SS, Inazawa M, Sinha N, Sawada S, Vergidis R, Diener E.

Transplantation. 1987 Dec;44(6):770-4.

PMID:
2892291
3.
4.
7.

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.

Waller EK, Boyer M.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S20-4.

PMID:
10933181
9.

Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras.

Rayfield LS, Brent L.

Transplantation. 1983 Aug;36(2):183-9.

PMID:
6349042
11.
12.

Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.

Sykes M, Bukhari Z, Sachs DH.

Bone Marrow Transplant. 1989 Sep;4(5):465-74.

PMID:
2790325
13.

Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.

Pillai A, Teo P, George T, Mukhopadhyay A, Dejbakhsh-Jones S, Strober S.

Bone Marrow Transplant. 2007 Sep;40(5):487-97. Epub 2007 Jul 2.

PMID:
17603512
15.

In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.

Kedar E, Tsuberi BZ, Landesberg A, Anafi M, Leshem B, Gillis S, Urdal DL, Slavin S.

Bone Marrow Transplant. 1988 Jul;3(4):297-314.

PMID:
3048495
16.

A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.

Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.

Biol Blood Marrow Transplant. 2004 Oct;10(10):669-80.

17.

Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.

Hornung RL, Longo DL, Bowersox OC, Kwak LW.

J Natl Cancer Inst. 1995 Sep 6;87(17):1289-96.

PMID:
7544833
19.

Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.

Weiss L, Weigensberg M, Morecki S, Bar S, Cobbold S, Waldmann H, Slavin S.

Cancer Immunol Immunother. 1990;31(4):236-42.

PMID:
2379219
20.

Supplemental Content

Support Center